CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Replek AD Skopje Company Snapshot
Replek AD Skopje operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Replek AD Skopje with three other pharmaceutical manufacturers in Europe: Amryt Pharma PLC of the United Kingdom (2017 sales of £11.18 million [US$15.66 million] ), Photocure ASA of Norway (150.91 million Norwegian Kroner [US$19.29 million] of which 57% was Hexvix/Cysview Own Sales), and Science In Sport Plc which is based in the United Kingdom (£15.62 million [US$21.87 million] ).

Sales Analysis. Replek AD Skopje reported sales of 955.23 million Denar (US$19.07 million) for the year ending December of 2017. This represents an increase of 15.2% versus 2016, when the company's sales were 829.32 million Denar.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Replek AD Skopje
  Stock Performance Chart for Replek AD Skopje
 
  Stock Data: Recent Stock Performance:
  Current Price (4/17/2018): 61,000
(Figures in Denar)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks n/a   52 Weeks n/a  
 
Replek AD Skopje Key Data:
  Ticker: REPL Country: Macedonia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 955,225,000
(Year Ending Jan 2018).
Employees: 352
  Currency: Denar Market Cap: 1,581,145,920
  Fiscal Yr Ends: December Shares Outstanding: 25,920
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.